Faron Pharmaceuticals to host investor R&D Day on bexmarilimab program

Reuters2026/09/10 06:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Faron Pharmaceuticals will host an R&D Day webcast on Oct. 8, 2026.
Event will review progress in the bexmarilimab clinical program across hematological cancers, including high-risk MDS, plus selected solid tumors.
Senior management will present alongside external clinical experts; session includes a panel Q&A.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faron Pharmaceuticals Oyj published the original content used to generate this news brief on September 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Faron Pharmaceuticals to host investor R&D Day on bexmarilimab program

You may also like

Crypto prices